1 / 26

Traumatic Brain Injury Diagnostic Challenges & Emerging Tools

Traumatic Brain Injury Diagnostic Challenges & Emerging Tools. Julie C. Chapman, PsyD. VA/DOD Definition of TBI. A traumatically induced structural injury AND/OR physiologic disruption of brain function as a result of an external force that is indicated by new onset or worsening of

Download Presentation

Traumatic Brain Injury Diagnostic Challenges & Emerging Tools

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Traumatic Brain Injury Diagnostic Challenges &Emerging Tools Julie C. Chapman, PsyD

  2. VA/DOD Definition of TBI • A traumatically induced structural injury AND/OR • physiologic disruption of brain function • as a result of an external force • that is indicated by new onset or worsening of • at least one of the following clinical signs • immediately following the event

  3. VA/DOD Definition of TBI • At least one of the following clinical signs immediately following the event: • Any period of loss of consciousness • Any loss of memory for events immediately before or after injury • Any alteration in mental state at the time of injury • Neurologic deficits • Intracranial lesion

  4. How is TBI Diagnosed? • 2nd Level TBI Evaluation: • Interview • Physical Examination • Neurobehavioral Symptom Inventory • TBI is often retrospectively diagnosed

  5. Severity of Injury • Three main indices: • Duration of Loss of Consciousness (LOC) or Alteration of Consciousness (AOC) • Post-Traumatic Amnesia (PTA) • Glasgow Coma Scale (GCS)

  6. Severity of Injury (VA/DOD)

  7. Diagnostic Challenges • Diagnostic criteria is based largely upon patient self-report, particularly in mild TBI. • Possible threats to diagnostic accuracy: • Recall bias • Cognitive difficulties • Other factors

  8. Diagnostic Challenges • Overlap of symptoms in co-morbid conditions: • Hoge et al. Study • Schneiderman et al. Study • RAND Study

  9. Symptom Overlap TBI PTSD Insomnia Memory problems Poor concentration Depression Anxiety Irritability Re-experiencing Avoidance Emotional numbing • Insomnia • Memory Problems • Poor concentration • Depression • Anxiety • Irritability • Headache • Dizziness • Fatigue • Noise/light intolerance

  10. Seeking Objective Markers • Biomarkers • Brain Imaging • Neurobehavioral Measures

  11. Biomarkers • S-100B • Calcium binding protein found in astroglial and Schwann cells • Sensitive but not specific for brain injury • Others: • GFAP = GlialFibrillary Acidic Protein • MBP = Myelin Basic Protein • NSE= Neuron Specific Enolase

  12. Diffusion Tensor Imaging • Measures the movement of water molecules in neurons. • Diffusion is an intrinsic physical process independent of the MR effect & magnetic field. • White matter tracts can be visualized and estimated in vivo.

  13. Diffusion Tensor Imaging • Lipton et al. 2009 - 20 pts (2 wks post mTBI), 20 matched controls. Reduced FA in frontal WM correlated with executive function tests (IntegNeuro: CPT & EMT). • Niogi et al. 2008 - 43 patients (16.9 mths post mTBI) and 23 controls. Attentional control correlated with FA in L corona radiata. Memory performance correlated with FA in uncinate fasciculus. • Rutgers et al. 2008 - 21 patients (5.5 mths post mTBI) and 11 controls. mTBI had reduced FA in cerebral lobar WM, cingulum and corpus callosum.

  14. Blast Injury Outcomes (BIO) Study • Sample of OEF/OIF Veterans and Controls with: • No prior TBI (even mild) • No current or recent or chronic substance abuse or dependence • All OEF/OIF Veterans have • Mild TBI from blast exposure and/or • Combat-related PTSD

  15. Blast Injury Outcomes (BIO) Study - Chapman

  16. Blast Injury Outcomes (BIO) Study-Chapman

  17. Neurobehavioral Measures • Heitger et al. 2009: Antisaccades and visual tracking more impaired in patients with post-concussive syndrome at avg of 140 days post-injury than controls • Wortzel et al. 2009: Presence of frontal release signs plus paratonia predicted cognitive and functional impairment in a acute TBI. • Chapman et al. 2010: Presence of visual tracking, frontal release signs and antisaccades predicted mTBI versus No TBI group.

  18. Integrative Diagnostics Patient Self-Report Objective Diagnostic Markers GESTALT

  19. All Hands on Deck Epidemiology Laboratory Science Clinical Science

  20. Integrative Diagnostics Clinical Algorithms

  21. Markers for the Identification, Norming & Differentiation (MIND) of TBI and PTSD Principal Investigator: Julie C. Chapman, PsyD Study Chair and Co-PI: Aaron Schneiderman, PhD • Tri-WRIISC Study (DC, East Orange, Palo Alto) • Clinical Research Evaluation of OEF/OIF Veterans from the Epidemiological Study

  22. Markers for the Identification, Norming & Differentiation of TBI and PTSD (MIND) • Four groups of OEF/OIF Veterans studied (total n=800): • Veterans with TBI • Veterans with PTSD • Veterans with both TBI and PTSD • Veterans with neither TBI nor PTSD

  23. Phase One AimsMIND Study • Aim 1: To validate the prevalence estimate of TBI and PTSD in OEF/OIF Veterans from the Epidemiological Study. • Aim 2: To assess the effectiveness of VHA screening instruments for TBI and PTSD in OEF/OIF Veterans.

  24. Phase Two AimsMIND Study • Aim 1: To identify sensitive & specific markers for both conditions from each measurement modality. • Aim 2: To develop prediction models for both conditions using multi-system, objective measures and patient self-report. • Measures include: • Cognitive • Sensorimotor • Advanced Neuroimaging • Sleep

  25. Phase Three AimsMIND Study • Aim 1: To identify sensitive & specific markers for TBI from each measurement modality. • Aim 2: To develop prediction models for TBI using multi-system, objective measures and patient self-report. • Measures include: • Neuroendocrine • Sleep Medicine

  26. Contact Us ADDRESS: Veterans Affairs Medical Center MS 127 Washington, DC 20422 PHONE: (202) 745-8249 EMAIL: Julie.Chapman@va.gov VISIT OUR WEBSITE: www.warrelatedillness.va.gov/dc/

More Related